JLK, Inc. Company Description

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea.

The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases.

The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology.

JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.

JLK, Inc.

Country	South Korea
Founded	2014
Industry	Conglomerates
Sector	Industrials
CEO	Dongmin Kim

Contact Details

Address: #204, 10, Yangcheongsongdae-gil Cheongju-si South Korea
Phone	82 7 04651 4051
Website	jlkgroup.com

Stock Details

Ticker Symbol	322510
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7322510009
SIC Code	7372

Key Executives

Name	Position
Dongmin Kim	Chief Executive Officer